Very early life microbiome and metabolome correlates with primary vaccination variability in children

mSystems. 2023 Oct 26;8(5):e0066123. doi: 10.1128/msystems.00661-23. Epub 2023 Aug 23.

Abstract

We show that simultaneous study of stool and nasopharyngeal microbiome reveals divergent timing and patterns of maturation, suggesting that local mucosal factors may influence microbiome composition in the gut and respiratory system. Antibiotic exposure in early life as occurs commonly, may have an adverse effect on vaccine responsiveness. Abundance of gut and/or nasopharyngeal bacteria with the machinery to produce lipopolysaccharide-a toll-like receptor 4 agonist-may positively affect future vaccine protection, potentially by acting as a natural adjuvant. The increased levels of serum phenylpyruvic acid in infants with lower vaccine-induced antibody levels suggest an increased abundance of hydrogen peroxide, leading to more oxidative stress in low vaccine-responding infants.

Keywords: antibiotics; children; metabolome; microbiome; vaccine response.

MeSH terms

  • Child
  • Gastrointestinal Microbiome*
  • Humans
  • Infant
  • Metabolome
  • Microbiota*
  • Vaccination
  • Vaccines*

Substances

  • Vaccines